As of 3:58pm ET
| -0.0009 / -6.98%|
PositiveID Corp. engages in the development of molecular diagnostic systems for bio-threat detection and rapid medical testing. It operates through the following segments: Molecular Diagnostics, Medical Devices, Mobile Labs, and Corporate. The Molecular Diagnostics segment develops molecular diagnostic systems for rapid medical testing and bio-threat detection. The Medical Devices segment markets and sells caregiver product through wholly-owned Thermomedics subsidiary. The Mobile Labs segment offers mobile laboratories, command and communications applications, and mobile cellular systems through ENG subsidiary. The company was founded in November 2001 and is headquartered in Delray Beach, FL.
|William J. Caragol||Chairman, Chief Executive Officer, CFO & Treasurer|
|Lyle L. Probst||President|
|Allison F. Tomek||Secretary & Senior VP-Corporate Development|